Top Minneapolis, MN Biotech Companies (67)
Established in 2001, Avalere Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Our team of 1,500+ experts combine their knowledge and expertise across our core disciplines—Consulting; Medical; Policy; Value, Evidence, and Access; Marketing; and Digital Experience Technology—to create the connections that make better health happen. We partner with our clients to navigate the complex and rapidly changing healthcare ecosystem. Together, our experts help clients connect patients with life-changing therapies, realizing the potential of strategies and solutions to accelerate innovation that improves lives.
Cell Culture Company is a biotech organization located in Minneapolis, MN. Headquarters include corporate offices, manufacturing operations, regulated clean room spaces, and a distribution center. C3 offers tools and services to the therapeutic, cell therapy, diagnostic, genomic, animal health, food safety and research industries. C3 team members are experts in aseptic technique, bioreactor manufacturing, cell culture, purification, quality control, analytics and regulatory compliance. C3 has supported 20+ FDA clinical trials and serviced 1,700+ global laboratories. We are a growing biotech company with opportunities for talented individuals who want to support life-saving products.
General Probiotics develops innovative cellbots, antimicrobial probiotics that eliminate harmful pathogens in livestock.
Recombinetics is a global leader in proprietary gene repair and gene-editing technology. Our breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing technologies has resulted in breakthroughs in the regenerative medicine, disease research and animal agriculture. Led by a team of expert geneticists, genome engineers, and reproductive physiologists, the company is headquartered in St. Paul, Minnesota.
DSI is a pioneering biomedical research company focused on systems physiology and pharmacology.
Metavention develops medical devices to help with interventional therapies for Type 2 diabetes.
OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors.
Pace® makes the world a safer, healthier place. Pace® People are committed to advancing the science of our customers in the pharmaceutical and biopharmaceutical industries. Pace® Life Sciences provides a full suite of contract CMC development, CTM manufacturing, regulatory compliance, consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries from our network of CDMO sites, GMP analytical testing laboratories, and manufacturing support service centers. Our experienced, highly trained industry experts, and our investment in state-of-the-art development and manufacturing facilities emphasizes our commitment to efficiently advancing client programs through the clinic to commercialization. We are dedicated to delivering the best and most reliable services with positive customer experiences across all channels of our business. A subsidiary of Pace® Science and Technology Company, Pace® Life Sciences operates a network of multiple CDMO sites, FDA-registered GMP analytical testing laboratories, and regulatory and manufacturing support service centers across the United States.
Enhanced Information Solutions provides Life Science manufacturers with mobile and computing technology to improve operations.
MicroOptx is an early-stage medical device company that leverages academic bioengineering.
Loam works with 4.5 billion years of evolution to solve the climate crisis. Microbes have changed the composition of our atmosphere through earth’s history. At Loam, we are ensuring these organisms can do it again. Through a better understanding of how microbes influence the carbon cycle, we can create new planetary-scale opportunities for carbon sequestration and improve agricultural productivity.
Tychon Bioscience is a biotechnology company commercializing adaptive immunotherapy technology.
Celcuity transform care for patients with cancer or autoimmune disease.
Stratix Labs is a biotechnology company develops products that accelerate the development and validation of disinfectants.
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.
Since 1996, Minnetronix Medical has accelerated medical device breakthroughs as a design, development and manufacturing partner to leading device companies around the world. Today, through life-cycle efficiency, opportunity realization, and increased utility, the organization is creating value in key technology segments, including RF energy, fluid and gas management, optical systems, and stimulation and active wearables. From design and manufacturing services to whole product solutions, Minnetronix brings expansive industry insight and intentional technical acumen, delivering better medical devices to market, faster. Minnetronix is based in St. Paul, Minnesota.
Conventus Orthopaedics is a provider of a range of orthopedic and sports medicine services.
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.
Access Genetics and OralDNA Labs are in the business of personalized diagnostics
Advanced BioEnergy is a liability company formed to develop, construct, own, and operate ethanol plants and other biofuels businesses.
Work Your Passion. Live Your Purpose.
